Company news

Genetic Technologies Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Hainan Invitation to discuss Market Entry into China

August 21, 2018

Proposed JV with Beijing Zishan Health Consultancy Limited

August 16, 2018

Lodgement of Prospectus and Appendix 3B

August 8, 2018

Swisstec Update

August 7, 2018

Formalisation of Strategic Alliance with Blockchain Global

August 2, 2018

Quarterly Activities Report & Appendix 4C - 30 June 2018

July 31, 2018

Expansion of Genetic Risk Assessment Tests

July 16, 2018

Swisstec Heads of Agreement

June 19, 2018

Binding Project Shivom Agreement

June 7, 2018

NHMRC Partnership Grant Awarded

May 1, 2018

Quarterly Activities Report & Appendix 4C - 31 March 2018

April 30, 2018

Research Agreement - Enhancement of Breast Cancer Risk Test

March 16, 2018

Project Shivom Strategic Alliance

March 6, 2018

Appendix 4D & Half Year Financial Report - 31 December 2017

February 26, 2018

Strategic Alliance and Capital Raising

February 15, 2018

Change of Chief Executive Officer

February 5, 2018

Voluntary Suspension from Official Quotation

January 31, 2018

Results from 31 January 2018 General Meeting

January 30, 2018

Quarterly Activities Report & Appendix 4C - 31 December 2017

January 29, 2018

Response to ASX Price Query

December 21, 2017

Update on Strategic Review Initiative

December 12, 2017

Quarterly Activities Report - 30 September 2017

October 30, 2017

Transition to Online Commercial Platform for BREVAGenplus

September 21, 2017

Appendix 4E and Financial Report 2017

August 29, 2017

Comprehensive Review of Strategic Alternatives

August 25, 2017

Breast Cancer Awareness Month Promotion for BREVAGenplus

July 31, 2017

Quarterly Activities Report & Appendix 4C - 30 June 2017

July 27, 2017

Nasdaq Deficiency Notice

July 21, 2017

Quarterly Activities Report & Appendix 4C - 31 March 2017

April 26, 2017

Change in Pricing and Billing Program

March 30, 2017

Partnership to Promote BREVAGenplus, Second Year

March 29, 2017

Appendix 4D and 31 December 2016 Half Year Financial Report

February 23, 2017

Quarterly Activities Report & Appendix 4C - 31 December 2016

January 27, 2017

AUD 8.1 Million Capital Raising

December 1, 2016

License Agreement to Develop Colorectal Cancer Risk Test

November 28, 2016

Quarterly Activities Report & Appendix 4C, 30 September 2016

October 26, 2016

Appendix 4E & Financial Report 2016

August 29, 2016

Quarterly Activities Report & Appendix 4C - 30 June 2016

July 28, 2016

New Generation Test - BREVAGenplus Launch

March 30, 2016

Appendix 4D and 31 December 2015 Half Year Financial Report

February 24, 2016

Partnership to promote BREVAGenplus

February 21, 2016

Appendix 4C - 31 December 2015

February 11, 2016

Key Scientific Results in Support of Brevagenplus

February 10, 2016

← Newer news releases

Decks

The 5 newest of 55 decks. Every deck is listed under its year.